(Total Views: 516)
Posted On: 05/13/2020 11:32:24 AM
Post# of 155556
Once this get CV19 approval we should expect a $5 to $10 billion orders for the rest of the year.
In accounting the revenue is considered in the time product is delivered. Although we get the money this year, it counts towards future revenue.
In the new presentation there is a revenue stream in the milestone chart. Kicking in Q3. Which is when the first deliveries take place.
It make sense to have as many manufacturers to be able to fulfill order of approved for CV19.
$10 billion with 90% margin as there is no middle man, is about $13 NAV per share the latest by this time next year. Id expect more of CV19 is around..
In accounting the revenue is considered in the time product is delivered. Although we get the money this year, it counts towards future revenue.
In the new presentation there is a revenue stream in the milestone chart. Kicking in Q3. Which is when the first deliveries take place.
It make sense to have as many manufacturers to be able to fulfill order of approved for CV19.
$10 billion with 90% margin as there is no middle man, is about $13 NAV per share the latest by this time next year. Id expect more of CV19 is around..
(0)
(1)
